Rakuten Medical
Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform. This platform integrates a drug, a device, and other components to deliver photoimmunotherapy, a treatment that combines a light-activated dye with a targeting agent to selectively destroy cancer cells. The company's lead asset, ASP-1929, is an antibody-dye conjugate currently approved in Japan for treating unresectable locally advanced or recurrent head and neck cancer. Rakuten Medical is conducting global clinical trials to evaluate the safety and efficacy of its therapies in combination with other treatments. The company also offers an Expanded Access Program to provide investigational products to patients with serious or life-threatening diseases who lack other treatment options. Rakuten Medical operates in multiple countries and focuses on developing new cancer treatments based on its Alluminox™ platform.
Domain
rakuten-med.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$100.0M
Founded
2009
Tech Stack (25 technologies)
Frequently Asked Questions
What technologies does Rakuten Medical use?+
Rakuten Medical uses 25 technologies including Google Analytics, Google Tag Manager, reCAPTCHA.
What industry is Rakuten Medical in?+
Rakuten Medical operates in the Biotechnology industry.
Where is Rakuten Medical based?+
Rakuten Medical is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026